Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Guided Antipsychotic Dose Reduction in Patients With Psychosis Under Remitted States: a Randomized Control Trial and Prospective Follow-up Study

NCT03248180 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03248180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03248180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Guided Antipsychotic Dose Reduction in Patients With Psychosis Under Remitted States: a Randomized Control Trial and Prospective Follow-up Study
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 24, 2017
Completion date
December 31, 2020
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis, remission